Glassman Wealth Services Beam Therapeutics Inc. Transaction History

Glassman Wealth Services

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$17.69 - $30.76 $459 - $799	26 Added 27.66%	120 $3,000
Q3 2023 Nov 13, 2023	BUY	$23.01 - $32.46 $2,047 - $2,888	89 Added 1780.0%	94 $2,000
Q2 2023 Aug 08, 2023	BUY	$29.32 - $35.99 $146 - $179	5 New	5 $0
Q2 2022 Aug 04, 2022	SELL	$29.86 - $62.36 $328 - $685	-11 Reduced 78.57%	3 $0
Q1 2022 Aug 23, 2022	BUY	$53.73 - $82.16 $752 - $1,150	14 New	14 $1,000

235

76.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.81B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.